A brand new medical trial finding out whether or not a compound derived from licorice root will have an effect on prostate most cancers in sufferers is now open on the College of Illinois Chicago. The examine would be the first to evaluate whether or not the pure product has anti-cancer results that might profit sufferers as they await surgical therapy.
The trial, managed by the College of Illinois Most cancers Middle, which is a part of UIC, highlights the college’s strengths in translational and community-engaged analysis. The medical examine is predicated on laboratory findings made by scientists in Rockford on the Faculty of Drugs. The brand new trial was additionally designed with group enter to higher attain and serve Black male sufferers, who are suffering increased mortality charges from prostate most cancers whereas remaining underrepresented in trials.
“Medical trials set the usual of look after prostate most cancers and different cancers, however only a few of them embody minority males,” stated Dr. Natalie Reizine, lead investigator of the trial. “So, it’s actually exhausting to extrapolate these medical trial outcomes to the sufferers that I’m seeing in clinic.”
The trial will enroll sufferers who’ve been lately identified with prostate most cancers. People will obtain glycyrrhizin — the lively compound in licorice root — within the weeks between prognosis and surgical procedure, and researchers will assess how the remedy impacts the development of most cancers.
Impressed by affected person demand and lab discovery
Licorice root is greatest recognized for its use as sweet or flavoring, however cultures world wide have used the plant for hundreds of years as a pure treatment. Just lately, medical trials have examined whether or not glycyrrhizin produces constructive results for sufferers with COVID-19, Parkinson’s illness or metabolic circumstances.
In a 2022 paper, the UIC analysis staff of Gnanasekar Munirathinam proposed that glycyrrhizin might be a promising anti-cancer agent. The analysis caught the attention of Reizine, a medical oncologist at UI Well being, the college’s well being system, who stated she usually fields questions from sufferers in regards to the function of pure dietary supplements in combating most cancers.
“After I have interaction with sufferers about dietary supplements, there’s much more mutual respect when it comes to speaking in regards to the significance of eating regimen and train,” stated Reizine, UIC assistant professor of medication and most cancers heart member. “So I puzzled if a medical trial centered on integrative drugs might doubtlessly be a facilitator for medical trial enrollment.”
Sufferers lately identified with prostate most cancers can be invited to enroll within the trial and people within the therapy group will obtain a each day dose of glycyrrhizin. Researchers will then assess how the remedy impacts biomarkers reminiscent of prostate-specific antigen and the pathology of tumor samples taken throughout surgical procedure.
A trial constructed with group enter
Reizine hopes that this trial will assist attain the populations most at risk of contracting and dying from prostate most cancers. Nationally, the illness happens earlier and extra usually in Black males, and males on Chicago’s West and South sides die from prostate most cancers 3 times greater than the citywide common.
To contain these sufferers, outreach and work with group companions is important. Reizine lately appeared on the Prostate Most cancers Actual Discuss podcast to speak in regards to the illness. She has additionally labored with the most cancers heart’s Workplace of Neighborhood Engagement and Well being Fairness to kind a group advisory board for the trial with leaders from organizations reminiscent of 100 Black Males of Chicago and Resolute Consulting Group.
The researchers and board will work collectively to make sure that the examine and dissemination of its outcomes align with group wants and views.
“The precise objective right here is to be reliable,” stated Yamilé Molina, affiliate director for group outreach and engagement on the most cancers heart and affiliate professor on the Faculty of Public Well being. “It’s about pondering by how we elevate group voice to be a part of examine management and dissemination.”
Contact 312-355-5112 or cancertrials@uic.edu for extra details about this trial from the most cancers heart medical trials workplace.
